85-6833-45　Etanercept Biosimilar - Research Grade 20mg　ICH4022

特徴

• 背景：Etanercept biosimilar is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. Etanercept biosimilar is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell expression system. It consists of 934 amino acids and has an apparent molecular weight of approximately 150 kilodaltons.

仕様

• サイズ：20mg
• ターゲット：TNF alpha
• 免疫動物：Humanized
• 交差性：Human
• 精製方法：This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
• 濃度：1.0 - 5.0 mg/ml
• 構成：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
• 純度：>95% by SDS-PAGE and HPLC
• エンドトキシン：≤ 0.75 EU/mg as determined by the LAL method
• データシート：https://www.ichor.bio/product/Etanercept-Biosimilar-Research-Grade-ich4022?action=genpdf&id=78788
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]